Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biomed Res Int
Glavni autori: Ohtake, Shinji, Kawahara, Takashi, Kasahara, Ryo, Ito, Hiroki, Osaka, Kimito, Hattori, Yusuke, Teranishi, Jun-ichi, Makiyama, Kazuhide, Mizuno, Nobuhiko, Umemoto, Susumu, Miyoshi, Yasuhide, Nakaigawa, Noboru, Miyamoto, Hiroshi, Yao, Masahiro, Uemura, Hiroji
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086366/
https://ncbi.nlm.nih.gov/pubmed/27822480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9846823
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items